Marquis L Cummings

Title: Marquis L. Cummings and His Work in Androgen Receptor Modulators.

Introduction

Marquis L. Cummings is an inventor associated with Encinitas, California, and Ligand Pharmaceuticals, Inc. His patent work concerns compounds designed to modulate androgen receptors.

Latest Patents

Cummings is credited with 1 patent: “Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods.” The patent describes non-steroidal tricyclic quinolinone and tricyclic quinoline compounds and compositions that can act as androgen receptor agonists, partial agonists, or antagonists. It also covers their preparation and potential uses.

Career Highlights

Cummings’s documented patent contribution reflects research into medicinal compounds that interact with androgen receptors. This work is associated with Ligand Pharmaceuticals, Inc.

Collaborations

The patent lists Jyun-Hung Chen and Anthony W. Thompson among Cummings’s collaborators, connecting their work on the disclosed compounds and methods.

Conclusion

Marquis L. Cummings’s patent contribution centers on tricyclic compounds developed to modulate androgen receptors, in collaboration with colleagues at Ligand Pharmaceuticals, Inc.